{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:03:36Z","timestamp":1784545416584,"version":"3.55.0"},"reference-count":218,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Epicardial adipose tissue (EAT) is a distinct form of visceral adipose tissue that lies within the pericardium and directly adjacent to the myocardium. Individuals with type 2 diabetes mellitus (T2DM) exhibit excessive and metabolically active EAT, which contributes to the development of early diabetic myocardial disease, formerly referred to as diabetic cardiomyopathy. Recent studies have demonstrated that excess EAT is characterized by a proinflammatory profile that may adversely affect the underlying myocardium, leading to impaired diastolic and systolic function. In this review, we discuss the role of excessive EAT as a source of proinflammatory and profibrotic cytokines that influence adjacent ventricular and atrial myocardium through local tissue crosstalk. In addition to metabolic alterations, enlarged EAT induces hemodynamic changes that result in pericardial constraint and enhanced ventricular interdependence, both of which are hallmarks of diabetic pericardial disease. We further analyze the interplay among T2DM, inflammation, obesity, and increased EAT on the one hand, and myocardial dysfunction characterized by myocardial stiffness, elevated filling pressures, and diastolic and systolic dysfunction on the other. We emphasize that the distinct immunometabolic activity of perivascular adipose tissue may lead to a paradigm shift in the understanding of coronary artery disease, moving from a predominantly endoluminal to an exoluminal perspective. A wide range of dietary, lifestyle, and pharmacological interventions are available within this emerging diabeto-cardiometabolic continuum, each with a potential role; however, the timing of intervention is crucial. This review also explores the potential effects of antidiabetic and other pharmacological agents that modulate EAT thickness, volume, and\/or activity, and discusses directions for future mechanistic and clinical research.<\/jats:p>","DOI":"10.3390\/medicina62071402","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:32:54Z","timestamp":1784539974000},"page":"1402","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epicardial\u00a0Adipose Tissue in Diabetic Heart Disease: Impact on Cardiac Function and Modulation Strategies, a Comprehensive Review"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0095-2987","authenticated-orcid":false,"given":"Ana","family":"\u0110uzel \u010cokljat","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, General Hospital Dubrovnik, 20000\u00a0Dubrovnik, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2587-1932","authenticated-orcid":false,"given":"Petra","family":"Grubi\u0107 Rotkvi\u0107","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, University Hospital Centre Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7060-8375","authenticated-orcid":false,"given":"Zdravko","family":"Babi\u0107","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Diseases, University Hospital Centre \u201cSestre Milosrdnice\u201d, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-3645","authenticated-orcid":false,"given":"Ivana","family":"Huljev \u0160ipo\u0161","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, University Hospital Dubrava, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1754-6299","authenticated-orcid":false,"given":"Marijo","family":"Beki\u0107","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Traumatology, General Hospital Dubrovnik, 20000 Dubrovnik, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8629-3008","authenticated-orcid":false,"given":"Marina","family":"Njire Brati\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Medical Biochemistry Laboratory, General Hospital Dubrovnik, 20000 Dubrovnik, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Rotkvi\u0107","sequence":"additional","affiliation":[{"name":"Clinic\u00a0for Cardiovascular Medicine Magdalena, 49217 Krapinske Toplice, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0750-9785","authenticated-orcid":false,"given":"Maja","family":"Cigrovski Berkovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Kinesiology, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","article-title":"Human epicardial adipose tissue is a source of inflammatory mediators","volume":"108","author":"Mazurek","year":"2003","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/oby.21059","article-title":"Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease","volume":"23","author":"McAninch","year":"2015","journal-title":"Obesity"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.echo.2009.10.013","article-title":"Echocardiographic epicardial fat: A review of research and clinical applications","volume":"22","author":"Iacobellis","year":"2009","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/cvr\/cvv208","article-title":"Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location","volume":"108","author":"Gaborit","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jcmm.14758","article-title":"Proteomics of epicardial adipose tissue in patients with heart failure","volume":"24","author":"Zhao","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.numecd.2017.05.010","article-title":"Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue","volume":"27","author":"Camarena","year":"2017","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.CIR.0000080378.96063.23","article-title":"Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100332","DOI":"10.1016\/j.xcrm.2021.100332","article-title":"Brown adipose tissue is associated with healthier body fat distribution and metabolic benefits independent of regional adiposity","volume":"2","author":"Wibmer","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.carpath.2008.02.006","article-title":"Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome","volume":"17","author":"Vural","year":"2008","journal-title":"Cardiovasc. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","article-title":"Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1152\/ajpendo.2001.280.5.E745","article-title":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance","volume":"280","author":"Kern","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1194\/jlr.R066597","article-title":"Oxidative stress and lipotoxicity","volume":"57","author":"Hauck","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1194\/jlr.R066514","article-title":"Lipid signaling and lipotoxicity in metaflammation: Indications for metabolic disease pathogenesis and treatment","volume":"57","author":"Ertunc","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides\u2014Lipotoxic Inducers of Metabolic Disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1194\/jlr.R067595","article-title":"The role of ER stress in lipid metabolism and lipotoxicity","volume":"57","author":"Han","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1152\/physiol.00037.2018","article-title":"Impact of Lipotoxicity on Tissue \u201cCross Talk\u201d and Metabolic Regulation","volume":"34","author":"Montgomery","year":"2019","journal-title":"Physiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J. Lipid Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.2337\/db07-0767","article-title":"Adipocyte death, adipose tissue remodeling, and obesity complications","volume":"56","author":"Strissel","year":"2007","journal-title":"Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jcb.22068","article-title":"Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells","volume":"106","author":"Sommer","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Johnston, E.K., and Abbott, R.D. (2023). Adipose Tissue Paracrine-, Autocrine-, and Matrix-Dependent Signaling during the Development and Progression of Obesity. Cells, 12.","DOI":"10.3390\/cells12030407"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2337\/diab.44.9.1121","article-title":"Effect of obesity on insulin resistance in normal subjects and patients with NIDDM","volume":"44","author":"Ludvik","year":"1995","journal-title":"Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/oxfordjournals.aje.a009158","article-title":"Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses\u2019 Health Study","volume":"145","author":"Carey","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"508409","DOI":"10.1155\/2015\/508409","article-title":"Mechanisms Linking Inflammation to Insulin Resistance","volume":"2015","author":"Chen","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"ref_31","first-page":"2907","article-title":"Tumor necrosis factor-alpha in sera of obese patients: Fall with weight loss","volume":"83","author":"Dandona","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"20878","DOI":"10.1038\/s41598-020-77914-1","article-title":"Regulators of TNF\u03b1 mediated insulin resistance elucidated by quantitative proteomics","volume":"10","author":"Mohallem","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/oxfordjournals.jbchem.a021998","article-title":"Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes","volume":"123","author":"Hirokawa","year":"1998","journal-title":"J. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2019.11.002","article-title":"Increased inflammation, oxidative stress and a reduction in antioxidant defense enzymes in perivascular adipose tissue contribute to vascular dysfunction in type 2 diabetes","volume":"146","author":"Azul","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12933-021-01420-5","article-title":"Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: A cross-sectional study","volume":"20","author":"Cosson","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.115.307765","article-title":"Increased Epicardial Adipose Tissue Volume Correlates with Cardiac Sympathetic Denervation in Patients with Heart Failure","volume":"118","author":"Parisi","year":"2016","journal-title":"Circ. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCRESAHA.116.308621","article-title":"Cardiac Sympathetic Denervation in the Failing Heart: A Role for Epicardial Adipose Tissue","volume":"118","author":"White","year":"2016","journal-title":"Circ. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/07315724.2014.933685","article-title":"Pericoronary adipose tissue: A novel therapeutic target in obesity-related coronary atherosclerosis","volume":"34","author":"Mazurek","year":"2015","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41419-021-04111-x","article-title":"Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation","volume":"12","author":"Hao","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2023.05.031","article-title":"Role of Human Epicardial Adipose Tissue-Derived miR-92a-3p in Myocardial Redox State","volume":"82","author":"Carena","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/eurheartj\/ehv625","article-title":"Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria","volume":"38","author":"Haemers","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jacc.2020.07.017","article-title":"Epicardial Adipose Tissue Accumulation Confers Atrial Conduction Abnormality","volume":"76","author":"Nalliah","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12967-023-04231-2","article-title":"Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation","volume":"21","author":"Meulendijks","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1253\/circj.CJ-18-0021","article-title":"Effect of the Epicardial Adipose Tissue Volume on the Prevalence of Paroxysmal and Persistent Atrial Fibrillation","volume":"82","author":"Oba","year":"2018","journal-title":"Circ. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e008161","DOI":"10.1161\/CIRCEP.119.008161","article-title":"Heterogeneity in Conduction Underlies Obesity-Related Atrial Fibrillation Vulnerability","volume":"13","author":"Heida","year":"2020","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jcu.22683","article-title":"Presence of fragmented QRS is associated with increased epicardial adipose tissue thickness in hypertensive patients","volume":"47","author":"Bekar","year":"2019","journal-title":"J. Clin. Ultrasound"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/europace\/euad102","article-title":"Relationship between epicardial adipose tissue measured by computed tomography and premature ventricular complexes originating from different sites","volume":"25","author":"Shen","year":"2023","journal-title":"Europace"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jacc.2021.08.037","article-title":"Modulation of Cardiac Arrhythmogenesis by Epicardial Adipose Tissue: JACC State-of-the-Art Review","volume":"78","author":"Ernault","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1210\/jc.2006-0584","article-title":"Myocardial triglyceride content and epicardial fat mass in human obesity: Relationship to left ventricular function and serum free fatty acid levels","volume":"91","author":"Lehto","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2019.06.009","article-title":"Epicardial adipose tissue thickness as an independent predictor of ventricular tachycardia recurrence following ablation","volume":"16","author":"Schoene","year":"2019","journal-title":"Heart Rhythm"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Grubi\u0107 Rotkvi\u0107, P., Planini\u0107, Z., Liberati Pr\u0161o, A.M., \u0160iki\u0107, J., Gali\u0107, E., and Rotkvi\u0107, L. (2021). The Mystery of Diabetic Cardiomyopathy: From Early Concepts and Underlying Mechanisms to Novel Therapeutic Possibilities. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115973"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/ejhf.3347","article-title":"Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases","volume":"26","author":"Paulus","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association","volume":"45","author":"Januzzi","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart Failure in Type 2 Diabetes Mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e008856","DOI":"10.1161\/JAHA.118.008856","article-title":"Burden of Uncontrolled Metabolic Risk Factors and Left Ventricular Structure and Function in Patients with Type 2 Diabetes Mellitus","volume":"7","author":"Jensen","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12933-019-0807-3","article-title":"Epicardial fat tissue in patients with diabetes mellitus: A systematic review and meta-analysis","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_59","first-page":"107640","article-title":"Epicardial adipose tissue in diabetic myocardial disorder: Role of echocardiography","volume":"16","year":"2025","journal-title":"World J. Diabetes"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/ejhf.2741","article-title":"Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: Mechanisms, management and modern perspectives","volume":"24","author":"Westenbrink","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jchf.2020.06.003","article-title":"Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure with Preserved Ejection Fraction","volume":"8","author":"Gorter","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e06","DOI":"10.15420\/cfr.2022.25","article-title":"Epicardial Fat in Heart Failure with Preserved Ejection Fraction: Bad Actor or Just Lying Around?","volume":"9","author":"Oduah","year":"2023","journal-title":"Card. Fail. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure with Preserved Ejection Fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.amjcard.2009.06.063","article-title":"Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus","volume":"104","author":"Ng","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Choy, M., Huang, Y., Peng, Y., Liang, W., He, X., Chen, C., Li, J., Zhu, W., Wei, F.F., and Dong, Y. (2023). Association between epicardial adipose tissue and incident heart failure mediating by alteration of natriuretic peptide and myocardial strain. BMC Med., 21.","DOI":"10.1186\/s12916-023-02836-4"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"106760","DOI":"10.1016\/j.crad.2024.106760","article-title":"Predictive value of epicardial adipose tissue volume for early detection of left ventricular dysfunction in patients suspected of coronary artery disease","volume":"81","author":"Li","year":"2025","journal-title":"Clin. Radiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ehf2.14744","article-title":"Impact of epicardial adipose tissue on cardiac function and morphology in patients with diastolic dysfunction","volume":"11","author":"Schulz","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_69","first-page":"601","article-title":"Epicardial Adipose Tissue Was Highly Associated with Reduction in Left Ventricular Diastolic Function as Early as in Adolescence","volume":"38","author":"Yang","year":"2022","journal-title":"Acta Cardiol. Sin."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5603\/KP.a2016.0139","article-title":"The effect of epicardial adipose tissue thickness on left ventricular diastolic functions in patients with normal coronary arteries","volume":"75","author":"Topuz","year":"2017","journal-title":"Kardiol. Pol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12933-020-01097-2","article-title":"Pericardial fat and its influence on cardiac diastolic function","volume":"19","author":"Altintas","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Setti, M., Benfari, G., Mele, D., Rossi, A., Ballo, P., Galderisi, M., Henein, M., and Nistri, S. (2020). Discrepancies in Assessing Diastolic Function in Pre-Clinical Heart Failure Using Different Algorithms-A Primary Care Study. Diagnostics, 10.","DOI":"10.3390\/diagnostics10100850"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"qyae056","DOI":"10.1093\/ehjimp\/qyae056","article-title":"Impact of epicardial adipose tissue on diastolic dysfunction in patients with chronic coronary syndrome and preserved left ventricular ejection fraction","volume":"2","author":"Ishikawa","year":"2024","journal-title":"Eur. Heart J.-Imaging Methods Pract."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.amjcard.2018.10.020","article-title":"Meta-Analysis of Relation of Epicardial Adipose Tissue Volume to Left Atrial Dilation and to Left Ventricular Hypertrophy and Functions","volume":"123","author":"Mancio","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/dom.13758","article-title":"Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetes","volume":"21","author":"Christensen","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2011.10.014","article-title":"Weight change modulates epicardial fat burden: A 4-year serial study with non-contrast computed tomography","volume":"220","author":"Nakazato","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.amjcard.2006.12.042","article-title":"Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography","volume":"99","author":"Willens","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1016\/j.ijcard.2013.04.202","article-title":"Effects of bariatric surgery on cardiac remodeling: Clinical and pathophysiologic implications","volume":"168","author":"Graziani","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Henry, J.A., Abdesselam, I., Deal, O., Lewis, A.J., Rayner, J., Bernard, M., Dutour, A., Gaborit, B., Kober, F., and Soghomonian, A. (2023). Changes in epicardial and visceral adipose tissue depots following bariatric surgery and their effect on cardiac geometry. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1092777"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/0118715303310680240607114244","article-title":"Open-bore MRI Scanner Assessment of Epicardial Adipose Tissue after Bariatric Surgery: A Pilot Study","volume":"25","author":"Asteria","year":"2025","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/met.2020.0008","article-title":"Associations of Visceral, Subcutaneous, Epicardial, and Liver Fat with Metabolic Disorders up to 14 Years After Weight Loss Surgery","volume":"19","author":"Hunt","year":"2021","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_82","first-page":"6542","article-title":"Susceptibilities of epicardial and subcutaneous fat tissue for browning-gene expression and diet-induced volume reduction are different","volume":"17","author":"Mikamo","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Kuleta, K., Krauz, K., \u017bmuda, J., Momot, K., Zar\u0119bi\u0144ski, M., Poprawa, I., and Wojciechowska, M. (2025). Pharmacological and Non-Pharmacological Interventions in Diabetes Mellitus: Effects on Epicardial Adipose Tissue. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199271"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/eurjpc\/zwad355","article-title":"Mediterranean diet and epicardial adipose tissue in patients with atrial fibrillation treated with ablation: A substudy of the \u2018PREDIMAR\u2019 trial","volume":"31","author":"Goni","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Derosa, G., D\u2019Angelo, A., Angelini, F., Belli, L., Cicero, A.F.G., Da Ros, R., De Pergola, G., Gaudio, G.V., Lupi, A., and Sartore, G. (2024). Nutraceuticals and Supplements in Management of Prediabetes and Diabetes. Nutrients, 17.","DOI":"10.3390\/nu17010014"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e47436","DOI":"10.1097\/MD.0000000000047436","article-title":"Effects of different vitamin D supplements on body fat distribution and glucolipid metabolism in patients with obesity-associated metabolic syndrome: A meta-analysis","volume":"105","author":"Huang","year":"2026","journal-title":"Medicine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamacardio.2019.2074","article-title":"Effect of Aerobic and Resistance Exercise on Cardiac Adipose Tissues: Secondary Analyses from a Randomized Clinical Trial","volume":"4","author":"Christensen","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/ndt\/gfq106","article-title":"Intradialytic exercise training reduces oxidative stress and epicardial fat: A pilot study","volume":"25","author":"Wilund","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_90","first-page":"2193","article-title":"A Short-Term Circuit Resistance Programme Reduced Epicardial Fat in Obese Aged Women","volume":"32","author":"Rosety","year":"2015","journal-title":"Nutr. Hosp."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1152\/japplphysiol.90756.2008","article-title":"Aerobic exercise training reduces epicardial fat in obese men","volume":"106","author":"Kim","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1507\/endocrj.EJ24-0377","article-title":"Effects of breaking up prolonged sitting via exercise snacks intervention on the body composition and plasma metabolomics of sedentary obese adults: A randomized controlled trial","volume":"72","author":"Zhou","year":"2025","journal-title":"Endocr. J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1249\/MSS.0000000000001232","article-title":"Exercise Training Reduces Intrathoracic Fat Regardless of Defective Glucose Tolerance","volume":"49","author":"Honkala","year":"2017","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5152\/dir.2018.18037","article-title":"Quantification of epicardial fat with cardiac CT angiography and association with cardiovascular risk factors in symptomatic patients: From the ALTER-BIO registry","volume":"25","author":"Milanese","year":"2019","journal-title":"Diagn. Interv. Radiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/14017431.2014.942872","article-title":"Correlation between epicardial fat and cigarette smoking: CT imaging in patients with metabolic syndrome","volume":"48","author":"Monti","year":"2014","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12012-020-09598-y","article-title":"Environmental Tobacco Smoke Exposure Estimated Using the SHSES Scale and Epicardial Adipose Tissue Thickness in Hypertensive Patients","volume":"21","author":"Gac","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"101996","DOI":"10.1016\/j.smrv.2024.101996","article-title":"Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments","volume":"78","author":"Messineo","year":"2024","journal-title":"Sleep Med. Rev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.2109080","article-title":"Epidemiology of obstructive sleep apnea","volume":"165","author":"Young","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"wjaf009","DOI":"10.1093\/obendo\/wjaf009","article-title":"Epicardial fat and sleep apnea: Perspective mechanisms, diagnostics, and therapeutics","volume":"1","author":"Varghese","year":"2025","journal-title":"Obes. Endocrinol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/MCP.0000000000001122","article-title":"Hypoxic burden: Definitions, pathophysiological concepts, methods of evaluation, and clinical relevance","volume":"30","author":"Parekh","year":"2024","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"113897","DOI":"10.1016\/j.expneurol.2021.113897","article-title":"Impact of intermittent hypoxia on human vascular responses during sleep","volume":"347","author":"Beaudin","year":"2022","journal-title":"Exp. Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"231","DOI":"10.31083\/j.rcm2506231","article-title":"Hypoxia-Induced Insulin Resistance Mediates the Elevated Cardiovascular Risk in Patients with Obstructive Sleep Apnea: A Comprehensive Review","volume":"25","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11325-015-1236-5","article-title":"CPAP therapy induces favorable short-term changes in epicardial fat thickness and vascular and metabolic markers in OSAHS","volume":"20","author":"Kostopoulos","year":"2016","journal-title":"Sleep. Breath."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Palanisamy, S., Yien, E.L.H., Shi, L.W., Si, L.Y., Qi, S.H., Ling, L.S.C., Lun, T.W., and Chen, Y.N. (2018). Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients. Pharmacy, 6.","DOI":"10.3390\/pharmacy6030057"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1365-2265.2008.03411.x","article-title":"Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis","volume":"70","author":"Wang","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.echo.2017.12.006","article-title":"Dobutamine Stress Echocardiography Unmasks Early Left Ventricular Dysfunction in Asymptomatic Patients with Uncomplicated Type 2 Diabetes: A Comprehensive Two-Dimensional Speckle-Tracking Imaging Study","volume":"31","author":"Philouze","year":"2018","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Altara, R., Giordano, M., Nord\u00e9n, E.S., Cataliotti, A., Kurdi, M., Bajestani, S.N., and Booz, G.W. (2017). Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction. Front. Endocrinol., 8.","DOI":"10.3389\/fendo.2017.00160"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(15)00044-3","article-title":"Glucose lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: A meta-analysis of randomized controlled trials","volume":"3","author":"Udell","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/13813455.2013.796996","article-title":"Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis","volume":"119","author":"Cignarelli","year":"2013","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1464-5491.2001.00509.x","article-title":"Contraindications to metformin therapy in patients with Type 2 diabetes\u2014A population-based study of adherence to prescribing guidelines","volume":"18","author":"Boyle","year":"2001","journal-title":"Diabet. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.repc.2018.08.010","article-title":"Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients","volume":"38","author":"Ziyrek","year":"2019","journal-title":"Rev. Port. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1017\/S1047951120002103","article-title":"Effects of metformin on epicardial adipose tissue and atrial electromechanical delay of obese children with insulin resistance","volume":"30","author":"Gunes","year":"2020","journal-title":"Cardiol. Young"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1111\/jcmm.15407","article-title":"Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/j.fertnstert.2011.02.004","article-title":"Link between metformin and the peroxisome proliferator-activated receptor gamma pathway in the uterine tissue of hyperandrogenized prepubertal mice","volume":"95","author":"Elia","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1194\/jlr.M053058","article-title":"12\/15-Lipoxygenase metabolites of arachidonic acid activate PPAR\u03b3: A possible neuroprotective effect in ischemic brain","volume":"56","author":"Sun","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.abb.2017.01.005","article-title":"Metformin and low dose radiation modulates cisplatin-induced oxidative injury in rat via PPAR-gamma and MAPK pathways","volume":"616","author":"Mansour","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0035-1569287","article-title":"Relationship of Serum Adiponectin Levels and Metformin Therapy in Patients with Type 2 Diabetes","volume":"48","author":"Su","year":"2016","journal-title":"Horm. Metab. Res."},{"key":"ref_119","first-page":"41","article-title":"The effects of metformin on inflammatory mediators in obese adolescents with insulin resistance: Controlled randomized clinical trial","volume":"25","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/oby.21718","article-title":"Liraglutide causes large and rapid epicardial fat reduction","volume":"25","author":"Iacobellis","year":"2017","journal-title":"Obesity"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"PROactive Investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13098-017-0290-5","article-title":"Effects of pioglitazone therapy on blood parameters, weight and BMI: A meta-analysis","volume":"9","author":"Filipova","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e13675","DOI":"10.1111\/obr.13675","article-title":"The effect of thiazolidinediones on body fat redistribution in adults: A systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Zhang","year":"2024","journal-title":"Obes. Rev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/dom.14885","article-title":"Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes","volume":"25","author":"Moody","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2009-1441","article-title":"Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus","volume":"95","author":"Jonker","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2337\/dc10-2083","article-title":"Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: Changes associated with pioglitazone","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.biochi.2012.04.014","article-title":"Early induction of a brown-like phenotype by rosiglitazone in the epicardial adipose tissue of fatty Zucker rats","volume":"94","author":"Distel","year":"2012","journal-title":"Biochimie"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S2213-8587(19)30422-X","article-title":"Association of glucose-lowering medications with cardiovascular outcomes: An umbrella review and evidence map","volume":"8","author":"Zhu","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e1369","DOI":"10.1136\/bmj.e1369","article-title":"Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: Systematic review and meta-analysis","volume":"344","author":"Karagiannis","year":"2012","journal-title":"BMJ"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc23-S010","article-title":"10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12020-015-0710-y","article-title":"Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: A pilot study","volume":"51","author":"Paoli","year":"2016","journal-title":"Endocrine"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12933-021-01228-3","article-title":"A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: The ASSET study","volume":"20","author":"Hiruma","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jphs.2017.11.006","article-title":"The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure","volume":"135","author":"Hirose","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2337\/db15-1224","article-title":"Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice","volume":"65","author":"Mulvihill","year":"2016","journal-title":"Diabetes"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/eurjpc\/zwad050","article-title":"Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies","volume":"30","author":"Malavazos","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0043-109563","article-title":"Human Epicardial Fat Expresses Glucagon-Like Peptide 1 and 2 Receptors Genes","volume":"49","author":"Iacobellis","year":"2017","journal-title":"Horm. Metab. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00592-014-0710-z","article-title":"Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: An ultrasonography study","volume":"52","author":"Morano","year":"2015","journal-title":"Acta Diabetol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"bvz042","DOI":"10.1210\/jendso\/bvz042","article-title":"Effects of Semaglutide Versus Dulaglutide on Epicardial Fat Thickness in Subjects with Type 2 Diabetes and Obesity","volume":"4","author":"Iacobellis","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12933-023-01738-2","article-title":"Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: A systematic review and meta-analysis","volume":"22","author":"Myasoedova","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2019.04.039","article-title":"Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: A target to modulate cardiovascular risk?","volume":"292","author":"Dozio","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3803\/EnM.2016.31.1.80","article-title":"Effects of Short-Term Exenatide Treatment on Regional Fat Distribution, Glycated Hemoglobin Levels, and Aortic Pulse Wave Velocity of Obese Type 2 Diabetes Mellitus Patients","volume":"31","author":"Hong","year":"2016","journal-title":"Endocrinol. Metab."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: Asystematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12265-018-9795-z","article-title":"GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction","volume":"11","author":"Nguyen","year":"2018","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"C14","DOI":"10.1152\/ajpcell.00388.2010","article-title":"Glucose transport by human renal Na+\/D-glucose cotransporters SGLT1 and SGLT2","volume":"300","author":"Hummel","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4239\/wjd.v11.i7.269","article-title":"Sodium-glucose cotransporter 2 inhibitors\u2019 mechanisms of action in heart failure","volume":"11","author":"Bulj","year":"2020","journal-title":"World J. Diabetes"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12933-023-02091-0","article-title":"Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes","volume":"22","author":"Cinti","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvx186","article-title":"Effects of dapagliflozin on human epicardial adipose tissue: Modulation of insulin resistance, inflammatory chemokine production, and differentiation ability","volume":"114","author":"Agra","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-017-0658-8","article-title":"The effect of dapagliflozin treatment on epicardial adipose tissue volume","volume":"17","author":"Sato","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/dom.16107","article-title":"SGLT2 inhibitors reduce epicardial adipose tissue more than GLP-1 agonists or exercise interventions in patients with type 2 diabetes mellitus and\/or obesity: A systematic review and network meta-analysis","volume":"27","author":"Bao","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: A state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","article-title":"Adipokines: Molecular links between obesity and atheroslcerosis","volume":"288","author":"Lau","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.metabol.2018.02.002","article-title":"Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes","volume":"85","author":"Garvey","year":"2018","journal-title":"Metabolism"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00125-013-2856-6","article-title":"Estimating the effect of sulfonylurea on HbA1c in diabetes: A systematic review and meta-analysis","volume":"56","author":"Hirst","year":"2013","journal-title":"Diabetologia"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1479164112465442","article-title":"Association of sulphonylurea treatment with all-cause and cardiovascular mortality: A systematic review and meta-analysis of observational studies","volume":"10","author":"Forst","year":"2013","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.2337\/diacare.28.9.2093","article-title":"PRESERVE-beta: Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin","volume":"28","author":"Gerich","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of Insulin Action and Insulin Resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0168-8227(11)70014-6","article-title":"Insulin effects in muscle and adipose tissue","volume":"93","author":"Dimitriadis","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/dmrr.480","article-title":"The incidence of congestive heart failure associated with antidiabetic therapies","volume":"21","author":"Nichols","year":"2005","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_160","first-page":"1013","article-title":"Site-specific properties of pericardial and epicardial adipose tissue: The effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro","volume":"14","author":"Marchington","year":"1990","journal-title":"Int. J. Obes."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41390-024-03319-9","article-title":"Evaluation of epicardial adipose tissue in children with type 1 diabetes","volume":"97","author":"Trabzon","year":"2025","journal-title":"Pediatr. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"F974","DOI":"10.1152\/ajprenal.00149.2007","article-title":"Insulin\u2019s impact on renal sodium transport and blood pressure in health, obesity, and diabetes","volume":"293","author":"Tiwari","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_163","first-page":"42","article-title":"Body Composition and Epicardial Fat in Type 2 Diabetes Patients Following Insulin Detemir Versus Insulin Glargine Initiation","volume":"48","author":"Elisha","year":"2016","journal-title":"Horm. Metab. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.amjcard.2015.07.067","article-title":"Effects of atorvastatin (80 mg) therapy on quantity of epicardial adipose tissue in patients undergoing pulmonary vein isolation for atrial fibrillation","volume":"116","author":"Soucek","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00380-014-0505-8","article-title":"Impact of duration and dosage of statin treatment and epicardial fat thickness on the recurrence of atrial fibrillation after electrical cardioversion","volume":"30","author":"Cho","year":"2015","journal-title":"Heart Vessel."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijcard.2017.04.103","article-title":"Atorvastatin reduces cardiac and adipose tissue inflammation in rats with metabolic syndrome","volume":"240","author":"Yamada","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2012.12.051","article-title":"Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: A substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning)","volume":"61","author":"Alexopoulos","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/ATVBAHA.107.160663","article-title":"Effects of statins on adipose tissue inflammation: Their inhibitory effect on MyD88-independent IRF3\/IFN-beta pathway in macrophages","volume":"28","author":"Abe","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Busnelli, M., Manzini, S., Froio, A., Vargiolu, A., Cerrito, M.G., Smolenski, R.T., Giunti, M., Cinti, A., Zannoni, A., and Leone, B.E. (2013). Diet induced mild hypercholesterolemia in pigs: Local and systemic inflammation, effects on vascular injury-rescue by high-dose statin treatment. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080588"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5551\/jat.3632","article-title":"Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels","volume":"17","author":"Horiuchi","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.clinthera.2008.12.023","article-title":"Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: Results of the CAP (Comparative Atorvastatin Pleiotropic effects) study","volume":"30","author":"Bonnet","year":"2008","journal-title":"Clin. Ther."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12933-017-0528-4","article-title":"Regulation of visceral and epicardial adipose tissue for preventing car diovascular injuries associated to obesity and dia betes","volume":"16","author":"Egido","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacl.2017.02.016","article-title":"Effects of atorvastatin treatment on left ventricular diastolic function in peritoneal dialysis patients-the ALEVENT clinical trial","volume":"11","author":"Wu","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.atherosclerosis.2012.03.030","article-title":"Diastolic function parameters are improved by the addition of sim vastatin to enalapril-based treatment in hyper tensive individuals","volume":"222","author":"Beck","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mehy.2006.09.070","article-title":"Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property","volume":"69","author":"Li","year":"2007","journal-title":"Med. Hypotheses"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11745-017-4246-1","article-title":"Inhibition of angiotensin II-Induced cardiac fibrosis by atorvastatin in adiponectin knockout mice","volume":"52","author":"Choi","year":"2017","journal-title":"Lipids"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.metabol.2015.11.007","article-title":"Atorvastatin prevents advanced glycation end products (AGEs)-induced cardiac fibrosis via activating peroxisome proliferator-activated receptor gamma (PPAR-g)","volume":"65","author":"Chen","year":"2016","journal-title":"Metabolism"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/HJH.0000000000000184","article-title":"Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats","volume":"32","author":"Akahori","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/hr.2010.243","article-title":"Protective effects of statin on cardiac fibrosis and apoptosis in adrenomedullin-knockout mice treated with angiotensin II and high salt loading","volume":"34","author":"Yamamoto","year":"2011","journal-title":"Hypertens. Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1253\/circj.71.144","article-title":"Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes","volume":"71","author":"Chen","year":"2007","journal-title":"Circ. J."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"115132","DOI":"10.1016\/j.taap.2020.115132","article-title":"Long-term atorvastatin or the combination of atorvastatin and nicotinamide ameliorate insulin resistance and left ventricular diastolic dysfunction in a murine model of obesity","volume":"402","author":"Yang","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"111179","DOI":"10.1016\/j.biopha.2020.111179","article-title":"Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia","volume":"135","author":"Werida","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/clc.20287","article-title":"Assessment of regional systolic and diastolic functions affected by atorvastatin in coronary artery disease using tissue Doppler imaging","volume":"31","author":"Qie","year":"2008","journal-title":"Clin. Cardiol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/eurheartj\/ehv072","article-title":"The effect of statin therapy on heart failure events: A collaborative meta-analysis of unpublished data from major randomized trials","volume":"36","author":"Preiss","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijcard.2016.03.186","article-title":"The effect of statins on mortality in heart failure with preserved ejection fraction: A meta-analysis of propensity score analyses","volume":"214","author":"Fukuta","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.amjcard.2013.12.023","article-title":"Meta-analysis of the effect of statins on mortality in patients with preserved ejection fraction","volume":"113","author":"Liu","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1253\/circj.CJ-14-0865","article-title":"CHART-2 Investigators. Prognostic impact of statin use in patients with heart failure and preserved ejection fraction","volume":"79","author":"Nochioka","year":"2015","journal-title":"Circ. J."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijcard.2009.12.028","article-title":"Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study","volume":"146","author":"Ashton","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"997","DOI":"10.5114\/aoms\/189575","article-title":"Efficacy of statin therapy in reducing epicardial adipose tissue: A systematic review and meta-analysis","volume":"20","author":"Jamialahmadi","year":"2024","journal-title":"Arch. Med. Sci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","article-title":"Understanding the molecular mechanisms of statin pleiotropic effects","volume":"97","author":"German","year":"2023","journal-title":"Arch. Toxicol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2018.06.106","article-title":"Statin therapy modulates thickness and inflammatory profile of human epicardial adipose tissue","volume":"274","author":"Parisi","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.ATV.12.1.120","article-title":"A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"12","author":"Stary","year":"1992","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"39224","DOI":"10.31083\/RCM39224","article-title":"Epicardial Adipose Tissue: A Potential Target to Improve Left Ventricular Diastolic Dysfunction","volume":"26","author":"Ran","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1348913","DOI":"10.1155\/2020\/1348913","article-title":"PCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation","volume":"2020","author":"Dozio","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"ehaa946.3008","DOI":"10.1093\/ehjci\/ehaa946.3008","article-title":"Reduction of epicardial adipose tissue thickness with PCSK9 inhibitors","volume":"41","author":"Zelaya","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.numecd.2007.09.001","article-title":"Epicardial fat thickness: Relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity","volume":"18","author":"Malavazos","year":"2008","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"102950","DOI":"10.1016\/j.jksus.2023.102950","article-title":"Trimetazidine with an adjuvant therapy to normalize the circulating visfatin concentration: Future perspective and mechanistic strategies","volume":"35","author":"Maheswari","year":"2023","journal-title":"J. King Saud. Univ.\u2013Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s40265-014-0233-5","article-title":"Defining the role of trimetazidine in the treatment of cardiovascular disorders: Some insights on its role in heart failure and peripheral artery disease","volume":"74","author":"Chrusciel","year":"2014","journal-title":"Drugs"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1291537","DOI":"10.1155\/2016\/1291537","article-title":"Epicardial Fat: Physiological, Pathological, and Therapeutic Implications","volume":"2016","author":"Salazar","year":"2016","journal-title":"Cardiol. Res. Pract."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/21623945.2015.1131881","article-title":"ACE2\/Ang 1-7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity","volume":"5","author":"Patel","year":"2016","journal-title":"Adipocyte"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/mrm.29348","article-title":"Accelerated fatty acid composition MRI of epicardial adipose tissue: Development and application to eplerenone treatment in a mouse model of obesity-induced coronary microvascular disease","volume":"88","author":"Shah","year":"2022","journal-title":"Magn. Reson. Med."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity related changes in expression of adiponectin, peroxisome proliferator-activated receptor gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/JOE-17-0351","article-title":"Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance","volume":"235","author":"Wada","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ejhf.792","article-title":"Effect of eplerenone in patients with heart failure and reduced ejection fraction: Potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial","volume":"19","author":"Olivier","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Mitchell, C.S., Premaratna, S.D., Bennett, G., Lambrou, M., Stahl, L.A., Jois, M., Barber, E., Antoniadis, C.P., Woods, S.C., and Cameron-Smith, D. (2021). Inhibition of the Renin-Angiotensin System Reduces Gene Expression of Inflammatory Mediators in Adipose Tissue Independent of Energy Balance. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.682726"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jchf.2016.11.015","article-title":"Interaction Between Spironolactone and Natriuretic Peptides in Patients with Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial","volume":"5","author":"Anand","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCHEARTFAILURE.111.962654","article-title":"Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: Findings from the I-PRESERVE trial","volume":"4","author":"Anand","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s00125-007-0614-3","article-title":"Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue","volume":"50","author":"Moro","year":"2007","journal-title":"Diabetologia"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"9807","DOI":"10.1038\/s41598-017-10240-1","article-title":"Over expression of C-type natriuretic peptide in endothelial cells protects against insulin resistance and inflammation during diet-induced obesity","volume":"7","author":"Bae","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.070371497","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide","volume":"97","author":"Tamura","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.cardfail.2014.06.357","article-title":"Genetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide","volume":"20","author":"Lanfear","year":"2014","journal-title":"J. Card. Fail"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ijo.2010.227","article-title":"Neprilysin, obesity and the metabolic syndrome","volume":"35","author":"Standeven","year":"2011","journal-title":"Int. J. Obes."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1152\/ajpregu.00499.2015","article-title":"Insulin\/glucose induces natriuretic peptide clearance receptor in human adipocytes: A metabolic link with the cardiac natriuretic pathway","volume":"311","author":"Bordicchia","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"eaam6870","DOI":"10.1126\/scisignal.aam6870","article-title":"Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance","volume":"10","author":"Wu","year":"2017","journal-title":"Sci. Signal"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"7","DOI":"10.36011\/cpp.2022.4.e5","article-title":"Anti-inflammatory effects of colchicine on coronary artery disease","volume":"4","author":"Park","year":"2022","journal-title":"Cardiovasc. Prev. Pharmacother."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"A442","DOI":"10.1016\/S0735-1097(14)60442-3","article-title":"Correlation between Colchicine Effects on Early Atrial Fibrillation Recurrence after Ablation and Left Atrium Epicardial Adipose Tissue Volume","volume":"63","author":"Egami","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"A895","DOI":"10.1016\/j.jacc.2026.02.2208","article-title":"26-A-20880-ACC The Effect of Colchicine on Epicardial Adipose Tissue by Serial CCTA: Insights from the Ekstrom Trial","volume":"87","author":"Lakshamanan","year":"2026","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1402\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:15:13Z","timestamp":1784542513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":218,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071402"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071402","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}